NCT00621660

Brief Summary

The aim of this study is to evaluate if acupuncture prevents or reduces nausea or vomiting during radiotherapy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
237

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2004

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2004

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2007

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 11, 2008

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 22, 2008

Completed
Last Updated

February 22, 2008

Status Verified

November 1, 2007

Enrollment Period

3.2 years

First QC Date

February 11, 2008

Last Update Submit

February 21, 2008

Conditions

Keywords

Acupuncture therapyCancerEmesisExpectationsPlacebo

Outcome Measures

Primary Outcomes (1)

  • Number of patients with at least one episode of nausea during the whole radiotherapy treatment period

    The radiotherapy treatment period (md 5 weeks)

Secondary Outcomes (1)

  • Secondary outcome measures are the summed number of days with nausea, intensity of nausea, number of patients and summed number of days with vomiting, belief in the antiemetic effects and interest in receiving needling in the future

    From acupunture start until 4 weeks after treatment stopped

Study Arms (2)

Acupuncture

EXPERIMENTAL
Procedure: Acupuncture

Sham

PLACEBO COMPARATOR
Procedure: Sham

Interventions

AcupuncturePROCEDURE

Acupuncture was administered bilaterally to the standard antiemetic point2-4 pericardium six (PC6) located between the tendons of palmaris longus and flexor carpii radialis at two body-inches proximal of the wrist crease. Sharp needles, diameter 0.25 x length 40 millimetres, were inserted into a depth of a half body-inch. One body-inch (or a "cun" in traditional Chinese medicine context) is equivalent to the greatest width of the individual patients´ thumb at the distal phalanx, approximately one and a half centimetres or one American thumb. The needles were manipulated three times (at the start, middle and end of the treatment session) by twirling, thrusting and lifting until deqi occurred.

Also known as: Invasive acupuncture
Acupuncture
ShamPROCEDURE

Sham acupuncture was administered bilaterally to a non-acupuncture point two body-inches proximal of PC6 with the telescopic Park sham device16, 0.30 x 40 millimetres (fully extended length). That needle looks identical with a real needle but is blunted and glides upwards into its handle instead of penetrating, which gives an illusion of penetration. The marking tubes hold the needles in place. The therapist gave an illusion of manipulation by turning the needle three times, each time for a couple of seconds until the needle touched the skin, but no deqi occurred. Except when placing and manipulating the sham needle, it was not pressed against the skin at all.

Also known as: Sham acupuncture, Placebo acupuncture
Sham

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients of at least 18 years of age
  • with gynaecologic-, anal-, rectal-, colon-, ventricle-, pancreatic- or testicular tumours
  • willing to give their informed consent
  • able to take part in the entire treatment and data collection procedure
  • had planned radiation over an abdominal and/or pelvic field (with or without concomitant chemotherapy) with the volume of at least 800 cm3 and a dose of at least 25 Gy.

You may not qualify if:

  • use of antiemetic treatment or persistent nausea within 24 hours prior to the start of radiotherapy
  • ever received acupuncture against nausea, or during the last year received acupuncture for any indication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sussanne Börjeson

Linköping, 58185, Sweden

Location

Related Publications (3)

  • Efverman A, Kristofferzon ML. A Basis for Strengthening Coping Strategies and Treatment Expectations in Patients Undergoing Emetogenic Pelvic-Abdominal Radiotherapy: A Longitudinal Study. Integr Cancer Ther. 2024 Jan-Dec;23:15347354241281329. doi: 10.1177/15347354241281329.

  • Blom K, Efverman A. Sleep During Pelvic-Abdominal Radiotherapy for Cancer: A Longitudinal Study With Special Attention to Sleep in Relation to Nausea and Quality of Life. Cancer Nurs. 2021 Jul-Aug 01;44(4):333-344. doi: 10.1097/NCC.0000000000000826.

  • Enblom A, Lekander M, Hammar M, Johnsson A, Onelov E, Ingvar M, Steineck G, Borjeson S. Getting the grip on nonspecific treatment effects: emesis in patients randomized to acupuncture or sham compared to patients receiving standard care. PLoS One. 2011 Mar 23;6(3):e14766. doi: 10.1371/journal.pone.0014766.

MeSH Terms

Conditions

NauseaVomitingNeoplasms

Interventions

Acupuncture Therapysalicylhydroxamic acid

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Sussanne Börjeson, PhD

    Linkoeping University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 11, 2008

First Posted

February 22, 2008

Study Start

January 1, 2004

Primary Completion

March 1, 2007

Study Completion

March 1, 2007

Last Updated

February 22, 2008

Record last verified: 2007-11

Locations